AmMed Direct tops Nashville Business Journal’s list of the 25 Fastest-Growing Companies

AmMed Direct, a Nashville-based provider of diabetes testing supplies, prescription medications and support services for people with diabetes, has been named the fastest-growing private company in the Middle Tennessee area by the Nashville Business Journal. The company topped the Nashville Business Journal’s list of the 25 Fastest-Growing Companies.

AmMed Direct’s revenue has grown 1,130 percent over the past three years, while the number of employees has grown from 160 at the beginning of 2007 to almost 500 today.

“We are extremely proud of the success our company has experienced in recent years and are pleased to be recognized by the Nashville Business Journal,” said Tom Milam, chief operating officer of AmMed Direct. “We have worked hard to develop a business model that is focused not only on growth, but also on quality patient care made possible by all our loyal and dedicated employees.”

Much of AmMed Direct’s growth can be attributed to its direct interaction with patients, as well as the addition of the AmMed HomeCare Pharmacy in 2005.

The pharmacy operation serves patients in all 50 states and currently fills thousands of prescriptions every day. It recently earned Verified Internet Pharmacy Practice Sites (VIPPS) accreditation from the National Association of Boards of Pharmacy. VIPPS-certified pharmacies must demonstrate compliance with patient rights to privacy, authentication and security of prescription orders, adherence to a recognized quality assurance policy, and provision of meaningful consultation between patients and pharmacists.

AmMed Direct was honored at an awards luncheon and profiled in the August 28 issue of the Nashville Business Journal.

Source: AmMed Direct

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expert explores the expanding applications of GLP1 therapies